Trial in Progress: A Phase I Trial of BTX-A51 in Patients with Relapsed or Refractory AML or High-Risk MDS
Year: 2020
Type: article
Source: Blood
Authors: Brian J. Ball, Anthony S. Stein, Gautam Borthakur, Crystal Murray, Karin Kook, Kyle WH Chan, Eytan M. Stein
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3096561463
